EMS - Eastland Medical Systems

A bit of volume starting to cme together for ems, currently down, but the buy side looks very strong. 3 1/4 results out this week(might be some buying on the strength of these results.

Also see UNI announcement today, chairman quites. This stock is very dodgy, looks like ppl are jumping off board.

Re: EMS - PAP up and running

Huge news for ems, (announcement today re:listing on the S/A markets). If you read between the lines pap is ready to rumble. I will top up in the next little bit, hopefully get some at 14.5c!

banjo_pete said:

Anyone have any thoughts on ems, good or bad!!!

Click to expand...

Chart looks good, crossover of 10day EMA and 100 day EMA recently. What I don't understand, and admittedly I know nothing of EMS is how there revenue can go from 5.1mill (2004) to 8.3 mill (2005) and their net loss double to 2mill? This is not a good sign (also as their net assets decreased!)

And their latest 1mill profit for 2005 Ju-Dec, has that come from their own activities or just their investment in that AIM comp?

A good indication of where ems is at will be ts 3 1/4ly report which i have been told will be a cracker. Over 1 million in black is not out of question. EMS is a great company that's share price has suffered due to management taking a long time to market its key prodcts.

Re: EMS - Eastland Medical Systems great artical

International Medical Devices is taking a short cut to profitability in acquiring Response Medical Equipment for £6.3 million.

Chaired by Australian entrepreneur and major shareholder Lindsay Sandford and run by chief executive Chris Thomas, AIM-quoted International Medical holds the rights to specialist 'safe' hospital needles made by Sandford-linked West Australian concern Eastland Medical. IMD, which lost £316,000 in the year to August, boasts a range of 'safe' needles, led by its 'Clip On' model, which is swiftly retractable and replaceable and thus more likely to avoid needlestick injuries occurring especially when patients twitch on being injected.

Other IMD products include 'Safeline' needles for drips and 'Auto-Injector', which enables people far away from hospitals or doctors to inject themselves with easy-to-use, safely-retractable needles. 'Auto-Injector' was developed with the Australian military and the Pentagon to enable battlefield troops to inject themselves with morphine or adrenaline, as required, as quickly and safely as possible.

IMD, whose products are seen by fans as also having potential among HIV sufferers and others, has launched marketing trials for 'Clip On' in five hospitals. If these go well, the National Health Service Central Purchasing Agency will accelerate matters by issuing a 'special tender', with IMD as the sole bidder.

The NHS buys 136 million needles a year and IMD says it is targeting an initial 25 per cent of that with needles at 16p, 6p more than standard NHS ones but safer and less likely to incur hefty insurance premiums and legal claims. That would yield a 10p margin per needle and the company also aims to attack the 'less price sensitive' markets of Germany and other European states, as well as the USA.

Buying Response brings IMD into profits of £800,000 a year and £8.5 million turnover. Funding it has involved a £2.8 million share issue at 7p, as well as loan stock and future performance-related payments.

At 7.13p, the shares could pay a punt.

A bit of interest around for ems this morning.

Was told ems's trials in te NHS have gone very well, announcement to this affect out soon with $s attached.

Another goodannouncement out of EMS today. How big is this Co going to be! Distribution centres around the world. At last count thats 6 or 7 centres around the world. It looks to me that EMS is going for the Aus Market aswell! 50 million needles P/A, all helps! Also i noticed more activity over in the UK with announcements. More funding coming in.

news out of the uk

CEO Chris Thomas said, "International Medical Devices has enjoyed a very positive start to the year. The latest acquisition, Response Medical Equipment, has started well, and is planning to introduce a number of new product lines to its portfolio. In the near future, I look forward to updating shareholders on the progress of the launch of 'Clip-on', the company's pioneering safe needle, into the NHS."


Highlights



- Meddis acquisition continues to show healthy trading



- Response Medical acquisition bedding in well



- 'Clip-On' safety needle set for NHS trials during May and June



- Initial feedback from NHS clinicians very positive for 'Clip-On'



- Further potential acquisition opportunities identified



The group is now entering a period of positive growth, through its acquisitions and through the exploitation of the intellectual property rights. One exciting product, “Clip-On”, a safe needle device, is going to be trialed at five major NHS hospitals in the UK during May and June 2006. Initial feedback from clinicians has been very positive. Following the acquisitions noted above, the group is now focusing its revenue streams in three main market sectors, being Emergency Care, Acute Care, and Aged Care. The group will continue to seek additional acquisition opportunities to develop and maximise its position within these market sectors.

you can catch the whole thing on

http://www.londonstockexchange.co.uk/LSECWS/IFSPages/MarketNewsPopup.aspx?id=1230657&source=RNS

Look at OMI the other day, signs a contract with turemo and the share price goes up by 65% (3 million syringes over 12 months). Now ems are tooling up to sell 50 million to the NHS, what do you think that will do to ems share price! Not long now!

great announcement for ems

19th June 2006
The Manager,
Company Announcements Platform,
Australian Stock Exchange,
Level 4,20Bidge Steet,
Sydney. N.S.W.2000

MEDIA RELEASE.
EASTLAND SECURES 5.0 MILLION ClipOn ORDER
Eastland Medical Systems Ltd (Eastland@) have concluded a supply contract and received their
first substantial export order for 5.0 Million ClipOn "Safe" needle devices.
Following the recent visit to Australia by two Senior Executives from the U.K. based Response
Medical Equipment Ltd (Response), a 100% wholly owned subsidiary of International Medical
Devices Plc, to inspect Eastland's high tech component manufacturing facility and Eastland's
Australian operations, Response proceeded to place a contract order for the entire annual
production of Eastland's pilot plant.
ClipOn is a "safe" hypodermic needle designed to replace standard Luer needles on syringes,
making it more cost effective and functional than other current safe retractable syringes.
Eastland is initially targeting the 3ml and 5ml syringe markets for ClipOn and this segment
represents more than 60% of the total market for hypodermic needles.
As a consequence of further discussions on supply of ClipOn for the European and South
African markets, Eastland has revised their South African project by increasing the capacity of
the proposed production facility from 50.0 Million units to 100.0 Million units annually. With the
introduction of mass production and automated assembly lines, Eastland is confident that their
ClipOn "Safe" needle will be the most competitive product in the world safe needle market
while retaining industry standard profit margins.
Mr Don O'Sullivan, Eastland's CEO said, "The commissioning of the Pilot plant has proven up
the mass production systerns and allows Eastland to implement it's key facility in South Africa
with state of the art production that will reduce the cost of the product to levels we did not expect.
Eastland are confident of securing a major share of the world market for safe needles and
inquiry for ClipOn "Safe" needle from overseas is now placing production pressure on the
company. As a result of the 5.0 Ml order we now have no product available for the Australian and
Asian markets until our next stage of production corlmences later this year. Eastland intends to
proceed with its regularity approvals for Clip-On. Based on current inquiry for ClipOn from
overseas, it appears that the production capacity of the proposed South African facility will be
fully committed by the time the facility is commissioned."

EMS is a bargin buy right now, i have got back on them at 9.8 to 10.5 over the last week. New CEO looks like he has his head screwed on, share price is currently at lows, ems has taken over two companies last 1/4, this will add 1.5million to ems bottom line (4 million this next 1/4 is expected) Once CE mark comes thu ems will no longer be trading in the low teens. Once CE mark is completed then ems will stitch up contract with NHS. 50 million syringes first of all ( about 12.5 million revenue. O/S ems sister co IMD have forcast 1 million profit for thenext fin year, this also helps ems's bottom line! In my opinion EMS is a BUY!

please do your own research!

Do your own research, but i am buying as much as i can get my hands on, CE Mark is around the corner! this will coause ems to jump into ther 20c mark. EMS Will then start getting contracts will NHS and others, great at these levels

banjo_pete said:

Do your own research, but i am buying as much as i can get my hands on, CE Mark is around the corner! this will coause ems to jump into ther 20c mark. EMS Will then start getting contracts will NHS and others, great at these levels

Click to expand...

This stock is making lower lows and lower highs, why would you keep buying something that has not shown any indication of reversing the downtrend that its in? Too many other opportunities that are actually trending up at the moment to even consider this.

Cheers,

GOOD announcement today for ems, new CEO doing a great job, uk and germany should come together very soon and then listing in S/A with more money coming in! all looks good!

CanOz said:

This stock is making lower lows and lower highs, why would you keep buying something that has not shown any indication of reversing the downtrend that its in? Too many other opportunities that are actually trending up at the moment to even consider this.

Cheers,

Click to expand...

I agree, in this market there are that many stocks making new highs and in very steep, long uptrends why bother with a stock in such a steep downtrend with no sign of bottoming out.Every time there is a rise the sellers appear in their droves.

A big no no for me.

Re: EMS - Eastland Medical Systems BEEN TOLD EMS HAS SIGNED CONTRACT

13 December 2006
International Medical Devices PLC
(“IMD” or the “Company”)

CE Marking granted and contract renewal

Highlights

· ClipOn safe needle receives CE Marking for sales and distribution in Europe

· Renewed contract with the Ministry of Defence for supply of Welch Allyn Defibrillators

International Medical Devices Plc (AIM: INT), the fast-growing medical supply company targeting the medical consumables, cardiorespiratory, acute and aged care markets, announces the completion of the CE Marking process on the ‘ClipOn’ safe needle, full launch of the product expected Q1 2007, and a further contract with Welch Allyn for the supply of the PIC 50 Portable Intensive Care Defibrillator Units to the Ministry of Defence (“MoD”).


ClipOn needles

On 12 December 2006, IMD received full CE Marking for the ClipOn safe needle. IMD owns the patents for ClipOn in the UK, Eire, Spain, Portugal, France, Italy, Greece, Austria, Belgium, the Netherlands, Luxembourg, Denmark, Sweden, Norway, Finland, the United States of America, Canada and Mexico. ClipOn is designed to eliminate needlestick injuries amongst healthcare professionals due to its revolutionary design that allows the ClipOn needle to attach to all standard syringes. The CE Marking now provides the Company with the legal certificate to sell and distribute ClipOn to healthcare markets throughout these countries. Product marketing and sales will commence in Q1 2007. IMD is also initiating an application for U.S. Food and Drug Administration (FDA) approval for ClipOn in order to target the North American markets in the second half of 2007.


Defibrillators

Response Medical, IMD’s wholly owned subsidiary has been supplying the Welch Allyn PIC 50 Defibrillators to the Ministry of Defence since 2001 and the MoD has renewed its contract, reaffirming the continued supply of the product. Due to its rugged yet lightweight design, it is ideal to be used by the MoD in operational zones as it is capable of withstanding the varying environmental conditions imposed by use in the defence forces.

Commenting on the latest product update, CEO Chris Thomas stated:

“The updated MoD contract with Welch Allyn demonstrates the reliability of our defibrillator range and we are very happy to continue our relationship with the Ministry of Defence. To receive the CE marking on our ClipOn safe needle is a significant step forward. ClipOn can become one of the principal products in driving the Company’s organic growth to help reach our goal of becoming one of the major medical distributors in the UK and Europe. We have already received orders from the NHS for ClipOn. With an estimated global market for unsafe needles of 6 billion needles per year, IMD’s challenge is to substitute Clip On in the key markets in Western Europe and the Americas, for which IMD owns the patents.”

ENDS

International Medical Devices

Chris Thomas
CEO
+44 203 008 4960
Corporate Synergy

Ian Rice
+44 117 933 0020
Parkgreen Communications

Victoria Thomas
+44 207 493 3713

Notes to Editors

About IMD:

International Medical Devices Plc was admitted to AIM in November 2004 with the purpose of acquiring companies or businesses operating in the health and medical devices sector which have the prospect of delivering high return and significant capital growth.

Since September 2005, IMD has made three acquisitions that, in its audited 2006 financial statements, gave the IMD group a pro forma turnover of in excess of £10million.

www.imd-plc.com

END

Interest being shown in Germany, Eastland has doubled in the last week. Just been on the wallstreet.de site they are currently talking about ems. Guys other Australian sites to look at are hotcopper.com.au.

Nice movement from EMS 2DAY.

ems signs contract for 80 million p/a, up 30% currently